Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function

NCT04354818 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT04354818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04354818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA): a Multisite Registry and Optional Biorepository in People With COVID-19 and Selected Conditions Affecting Immune Function
Lead sponsor
Kirby Institute
Phase
Observational
Overall status
Unknown status
Start date
May 11, 2020
Completion date
April 27, 2022
Enrollment
27 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, covid-19, hiv-1-infection, immunosuppression disorders, primary immune deficiency disorder